Heartware International Inc. (HTWR)
-NasdaqGS 92.43 
1.86(1.97%) 3:59PM EDT
| Prev Close: | 94.29 |
|---|
| Open: | 94.43 |
|---|
| Bid: | N/A |
|---|
| Ask: | 94.80 x 100 |
|---|
| 1y Target Est: | 103.64 |
|---|
| Beta: | -0.17 |
|---|
| Next Earnings Date: | 4-Aug-13 |
|---|
| Day's Range: | 92.32 - 94.53 |
|---|
| 52wk Range: | 74.77 - 99.68 |
|---|
| Volume: | 157,677 |
|---|
| Avg Vol (3m): | 222,191 |
|---|
| Market Cap: | 1.53B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -5.59 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Still Neutral on HologicZacks(Wed 1:50PM EDT)
- BDX Teams Again With JDRFZacks(Wed 1:40PM EDT)
- Mindray to Takeover ZONAREZacks(Mon, Jun 17)
- InPlay: HeartWare receives conditional approval from FDA to enroll supplemental patient cohort in destination therapy trialBriefing.com(Mon, Jun 17)
- HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy TrialPR Newswire(Mon, Jun 17)
- Varian Links With Siemens SystemsZacks(Fri, Jun 14)
- Luminex Collaborates with NMTCZacks(Fri, Jun 14)
- HTWR Crosses Below Key Moving Average Levelat Forbes(Thu, Jun 13)
- HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be WebcastPR Newswire(Thu, Jun 13)
- HeartWare International Management Presents at Goldman Sachs Healthcare Conference (Transcript)at Seeking Alpha(Wed, Jun 12)
- HEARTWARE INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Jun 12)
- HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)PR Newswire(Wed, Jun 12)
- Masimo Wins a Major ClientZacks(Mon, Jun 10)
- Why Heartware International May Be About to Take Offat Motley Fool(Thu, Jun 6)
- Miss HTWR's $86.45 Offering But Think It's A Deal At $75?at Forbes(Tue, Jun 4)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 11.69 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -3.18 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.78 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | -1.98 |
|---|
Business Summary
HeartWare International, Inc., a medical device company, engages in developing and manufacturing miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States and internat...
View More